Multispecific immunomodulatory antigen-binding constructs

Provided herein are multispecific immunomodulatory antigen-binding constructs (MIACs) and compositions comprising the constructs. Also provided are methods of using the constructs and methods of making the constructs. Described herein is a multispecific immunomodulatory antigen-binding construct (MI...

Full description

Saved in:
Bibliographic Details
Main Authors SCHUETZ THOMAS JOSEPH, BOBROWICZ PIOTR, SABZEVARI HELEN, TIGHE ROBERT V III, SCHMIDT MICHAEL MARCH, METENOU SIMON
Format Patent
LanguageChinese
English
Published 19.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are multispecific immunomodulatory antigen-binding constructs (MIACs) and compositions comprising the constructs. Also provided are methods of using the constructs and methods of making the constructs. Described herein is a multispecific immunomodulatory antigen-binding construct (MIAC) polypeptide, comprising: an antigen-binding module I (ABMI) that binds specifically to an antigen expressed by a cancer cell; an antigen-binding module 2 (ABM2) that binds specifically to an activating receptor expressed by an effector immune cell, wherein binding of ABM2 to the activating receptor agonizes the activating receptor; and an antigen-binding module 3 (ABM3) that binds specifically to an inhibitory receptor expressed by the effector immune cell, wherein the binding of ABM3 to theinhibitory receptor antagonizes the inhibitory receptor, wherein ABMI, ABM2, and ABM3 are operably linked to each other, and optionally wherein each antigen binding module is capable of binding its respective antigen or rece
Bibliography:Application Number: CN201680012450